Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Noninvasive Biomarkers of Hepatic Fibrosis in Urea Cycle Disorders

NCT04612764 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT04612764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04612764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Noninvasive Biomarkers of Hepatic Fibrosis in Urea Cycle Disorders
Lead sponsor
Baylor College of Medicine
Phase
Observational
Overall status
Active, not recruiting
Start date
November 4, 2021
Completion date
December 31, 2026
Enrollment
62 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

argi deficiency, argininosuccinic aciduria, asl deficiency, ass deficiency, citrullinemia 1, hyperargininemia, ornithine transcarbamylase deficiency, urea cycle disorder